Platelet-activating factor antagonism and streptokinase-induced hypotension in clinical acute myocardial infarction

Clinical Science

Volumn 100, Issue 6, 2001, Pages 601-607

  Taylor, R ^a   Fatovich, D ^a   Hitchcock, T ^a   Morrison, C ^a   Curtis, L ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Hypotension; Lexipafant; Myocardial infarction; PAF inhibition; Platelet activating factor; Streptokinase

Indexed keywords

LEXIPAFANT; STREPTOKINASE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT INDICATION;

AGED; CREATINE KINASE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPOTENSION; IMIDAZOLES; LEUCINE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET ACTIVATING FACTOR; STREPTOKINASE; THROMBOLYTIC THERAPY;

EID: 0034995827     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20000272     Document Type: Article

References (25)

1. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
2. Thrombolysis for acute myocardial infarction
3. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
4. The hypotensive effect of intravenous streptokinase in patients with acute myocardial infarction
5. Streptokinase, complement activation and hypotension
6. The incidence and mechanism of hypotension following thrombolytic therapy for acute myocardial infarction with streptokinase-containing agents - Lack of relationship to pretreatment streptokinase resistance
7. Streptokinase-induced platelet activation involves antistreptokinase antibodies and cleavage of protease-activated receptor-1
8. Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction
9. Streptokinase-induced, antibody-mediated platelet aggregation: A potential cause of clot propagation in vivo
10. Streptokinase-induced platelet aggregation. Prevalence and mechanism
11. Factors that contribute to spontaneous platelet aggregation and streptokinase-induced aggregation in whole blood
12. Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils and platelet-activating factor
13. Perspectives in platelet-activating factor research
14. PAF antagonists as potential therapeutic agents in cardiac anaphylaxis and myocardial ischaemia
15. Role of platelet-activating factor in hypotension and platelet activation induced by infusion of thrombolytic agents in rabbits
16. Streptokinase induces intravascular release of platelet-activating factor in patients with acute myocardial infarction and stimulates its synthesis by cultured human endothelial cells
17. The scientific basis of medical therapy of acute pancreatitis. Could it work, and is there a role for lexipafant?
18. Occurrence of hypotension during streptokinase infusion in suspected acute myocardial infarction, and its relation to prognosis and metoprolol therapy
19. Contribution of platelets and platelet-activating factor (PAF) to the arrhythmogenic, haemodynamic and necrotic effects of acute myocardial ischaemia
20. The effects of a PAF antagonist on ischemic myocardial damage and arrhythmia in the dog
21. Effect of WEB 2086 on myocardial infarct size and regional blood flow in the dog
22. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review
23. Treatment of acute myocardial infarction by primary coronary angioplasty or intravenous thrombolysis in the "real world". One year results from a nationwide French survey
24. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction